COURTNEY CUZALINA: Open Payments
NPI 1750947321 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 26 payments from 12 companies in 2025. Trend: 2023 $475 · 2024 $403 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Novo Nordisk Inc | 3 | $51 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Ionis Pharmaceuticals, Inc. | 1 | $26 |
| CVRx, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Boston Scientific Corporation | 1 | $20 |
Products named: JARDIANCE, LEQVIO, LifeVest, CAMZYOS, Kerendia, Wegovy, TRYNGOLZA, Barostim Neo System.
Industry payments across OK — which companies pay providers there.
